Ingrid M. Libman, MD, PhD, MPH
- Associate Professor of Pediatrics and Epidemiology
- Director, Diabetes Program, UPMC Children's Hospital of Pittsburgh
Ingrid Libman, MD, PhD, is an Associate Professor in the Division of Endocrinology and Director of the Diabetes Program at UPMC Children’s Hospital of Pittsburgh. She also holds a secondary appointment in the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh. Her scientific interests focus on the etiology, prediction, prevention and management of diabetes in childhood.
Libman has extensive experience in the area of population-based epidemiology and clinical research, more recently evaluating the impact of obesity and insulin resistance in youth with type 1 diabetes and novel therapies for prevention and treatment of type 1 and type 2 diabetes in the pediatric population. Libman has been involved in numerous national and international multi-center studies over the years, having been Co-Chair of a multicenter clinical trial in the US to evalute the use of metformin in overweight adolescents with type 1 diabetes funded by JDRF, principal investigator for the Pittsburgh Center in the T1D Exchange funded by the Helmsley Foundation and currently principal investigator of the University of Pittsburgh center for the NIH funded TrialNet study.
Libman has been very committed to service at the national and international level. She has served as consultant for the Pan American Health Organization, as well as Chair of the Diabetes in Youth Interest Group of the American Diabetes Association and member of the Advisory Council of the International Society for Pediatric and Adolescent Diabetes.
Professional and Scientific Society Memberships
- American Diabetes Association (ADA), 1992-Present
- Latin American Diabetes Association (ALAD), 1993-Present
- European Association for the Study of Diabetes (EASD), 1998-2016
- International Society for Pediatric and Adolescent Diabetes (ISPAD), 2005-Present
- Society for Pediatric Research (elected member), 2010-Present
- Pediatric Endocrine Society (former Lawson Wilkins), 2011-Present
- The Endocrine Society, 2014-2017
- American Association of Clinical Endocrinology, 2017-Present
Education & Training
- MD, Rosario Medical School, 1991
- MPH, University of Pittsburgh, 1993
- PhD, Epidemiology, University of Pittsburgh, 1996
- Postdoctoral Fellow, University of Pittsburgh, 1996
- Research Fellow in Pediatric Endocrinology, UPMC Children's Hospital of Pittsburgh, 1996-1998
- Internship/Residency in Pediatrics, UPMC Children's Hospital of Pittsburgh, 1998-2001
- Fellowship in Pediatric Endocrinology, UPMC Children's Hospital of Pittsburgh, 2001-2004
March CA, Nanni M, Kazmerski TM, Siminerio LM, Miller E, Libman IM. Modern diabetes devices in the school setting: Perspectives from school nurses”. Pediatric Diabetes 2020 April. Online ahead of print. [PMID: 32249474].
Shah V, Bailey R, Wu M, Foster N, Pop-Busui R, Katz M, Crandall J, Bacha F, Nadeau K, Libman I, Hiers P, Stout K, DiMeglio L, Sherr J, Prately R, Agarwal S, Snell-Bergeon J, Cengiz E, Polsky S, Mehta S. “Risk Factors for Cardiovascular Disease in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry”. J Clin Endocrinol Metab. 2020 May: 105(5). [PMID: 31955209].
Redondo M, Sosenko J, Libman I, McVean J, Tosur M, Atkinson M, Becker D, Geyer S. “Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated with Older Age and Insulin Resistance”. J Clin Endocrinol Metab. 2020 May: 105(5). [PMID:31867614].
Ferrara-Cook C, Geyer S, Evans-Molina C, Libman I, Becker D, Gitelman S, Redondo M, Type 1 Diabetes TrialNet Study Group. Diabetes Care 2020 March; 43(3): 580-87. [PMID: 31937610].
Ismail H, Becker D, Libman I, Herold K, Redondo M, Atkinson M, Cleves M, Palmer J, Sosenko J, Diabetes Prevention Trial (DPT-1) Study Group. “Early and late C-peptide responses during oral glucose tolerance testing are oppositvely predictive of type 1 diabetes in autoantibody-positive individuals”. Diabetes Obes Metab 2020 Jan. Online ahead of print. [PMID: 32003110].
Sims EK, Geyer S, Johnson SB, Libman I, Jacobsen LM, Boulware D, Rafkin LE, Matheson D, Atkinson MA, Rodriguez H, Spall M, Elding Larsson H, Wherrett DK, Greenbaum CJ, Krischer J, DiMeglio LA; Type 1 Diabetes TrialNet Study Group. “Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention”. Diabetes Care. 2019 Dec;42(12):2228-2236. [PMID: 31558546].
McGill JB, Wu M, Pop-Busui R, Mizokami-Stout K, Tamborlane WV, Aleppo G, Gubitosi-Klug RA, Haller MJ, Willi SM, Foster NC, Zimmerman C, Libman I, Polsky S, Rickels MR. “Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network.” J Diabetes Complications. 2019 Oct;33(10):107400. [PMID: 31279735].
Cree-Green M, Bergman BC, Cengiz E, Fox LA, Hannon TS, Miller K, Nathan B, Pyle L, Kahn D, Tansey M, Tichy E, Tsalikian E, Libman I, Nadeau KJ. “Metformin Improves Peripheral Insulin Sensitivity in Youth with Type 1 Diabetes”. J Clin Endocrinol Metab. 2019 Aug 1;104(8):3265-3278. [PMID: 30938764].
Helgeson VS, Orchard TJ, Seltman H, Becker D, Libman I. “Psychosocial predictors of diabetes risk factors and complications: An 11-year follow up. Health Psychol. 2019 Jul;38(7):567-576. [PMID: 30973749].
Ismail HM, Evans-Molina C, DiMeglio LA, Becker DJ, Libman I, Sims EK, Boulware D, Herold KC, Rafkin L, Skyler J, Cleves MA, Palmer J, Sosenko JM; Type 1 Diabetes Trial Net and Diabetes Prevention Trial-Type-1 (DPT-1) Study Groups. “Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes”. Pediatr Diabetes. 2019 Jun;20(4):408-413. [PMID: 30891858].
2U01DK106993-02, TrialNet Clinical Center Infrastructure Support Services, 2020-2025, NIH/University of South Florida
R01 DK115384-01A1, Teens with Type 1 Diabetes: A Focus on Friendship, 2018-2023, NIH/Carnegie-Mellon University
David Paul Diabetes Transition Care Research Fund, Transition to Adulthood for Adolescent Patients with T1DM, 2014-2020, Children’s Hospital Foundation
High Fidelity Wraparound in Type 1 Diabetes, 2018-2021, Children’s Hospital Foundation